Qube Research & Technologies Ltd

Position in MRNA — Moderna, Inc.

CIK 1729829 LONDON, X0

Back to MRNA Full portfolio

Position in MRNA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$35,595,153

+$35,595,153 QoQ

Shares Held

700,692

Ownership

0.177%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

19 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Mar 31, 2026

CallValue

$19,309,080

CallShares

380,100

PutValue

$52,064,920

PutShares

1,024,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. MRNA ranks #13 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

All Filings in MRNA

Export CSV

35 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,309,080	380,100	-45.8%	Call	Sole	2026-05-15
2026-03-31	$35,595,153	700,692	-31.6%	Shares	Sole	2026-05-15
2026-03-31	$52,064,920	1,024,900	+28.1%	Put	Sole	2026-05-15
2025-12-31	$23,589,051	799,900	-55.8%	Call	Sole	2026-02-17
2025-12-31	$53,397,543	1,810,700	+14.6%	Put	Sole	2026-02-17
2025-09-30	$40,819,149	1,580,300	+79.6%	Put	Sole	2025-11-14
2025-09-30	$22,727,817	879,900	-52.4%	Call	Sole	2025-11-14
2025-06-30	$51,049,777	1,850,300	+9.5%	Put	Sole	2025-08-14
2025-06-30	$46,635,377	1,690,300	+35.0%	Call	Sole	2025-08-14
2025-03-31	$35,502,705	1,252,300	+7.5%	Put	Sole	2025-05-15
2025-03-31	$33,036,255	1,165,300	+127.6%	Call	Sole	2025-05-15
2024-12-31	$21,288,960	512,000	-52.7%	Put	Sole	2025-02-14
2024-12-31	$45,018,666	1,082,700	+268.7%	Call	Sole	2025-02-14
2024-12-31	$12,210,050	293,652	-45.5%	Shares	Sole	2025-02-14
2024-09-30	$36,021,370	539,000	+112.0%	Put	Sole	2024-11-14
2024-09-30	$16,994,869	254,300	+519.7%	Call	Sole	2024-11-14
2024-09-30	$2,742,302	41,034	-62.9%	Shares	Sole	2024-11-14
2024-06-30	$13,133,750	110,600	-32.9%	Put	Sole	2024-08-14
2024-06-30	$19,570,356	164,803	+84.3%	Shares	Sole	2024-08-14
2024-06-30	$10,616,250	89,400	+514.8%	Call	Sole	2024-08-14
2024-03-31	$1,549,595	14,542	-94.0%	Shares	Sole	2024-05-14
2024-03-31	$26,021,952	244,200	+756.8%	Put	Sole	2024-05-14
2024-03-31	$3,036,960	28,500	-73.0%	Call	Sole	2024-05-14
2023-12-31	$10,511,865	105,700	-74.1%	Call	Sole	2024-02-13
2023-12-31	$40,595,490	408,200	+223.5%	Put	Sole	2024-02-13
2023-09-30	$13,035,198	126,200	+77.2%	Call	Sole	2023-11-13
2023-09-30	$7,354,248	71,200	-21.7%	Put	Sole	2023-11-13
2023-03-31	$13,958,118	90,885	-56.7%	Shares	Sole	2023-05-15
2022-12-31	$37,676,731	209,758	+53.1%	Shares	Sole	2023-02-14
2022-06-30	$19,572,878	137,017	+202.5%	Shares	Sole	2022-08-15
2021-12-31	$11,504,786	45,298	+96.9%	Shares	Sole	2022-02-10
2021-09-30	$8,853,704	23,005	-47.1%	Shares	Sole	2021-11-12
2021-06-30	$10,223,744	43,509	-86.4%	Shares	Sole	2021-08-13
2020-12-31	$33,516,065	320,820	+809.4%	Shares	Sole	2021-02-16
2020-03-31	$1,056,636	35,280	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.